Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

A Morrow

Showing results (681-690 of 942) with videos related to

Pageof 95
Sort By:
Journal of Pediatric Surgery|December 10, 2014
Patterns of surgical practice in very low birth weight neonates born in the United States: a Vermont Oxford Network analysisEric A Sparks, Ivan M Gutierrez, Jeremy G Fisher, et al.
The American Journal of Cardiology|August 30, 2008
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials)Emmanouil S Brilakis, James A de Lemos, Christopher P Cannon, et al.
Journal of the American College of Cardiology|April 15, 2014
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseJacob A Udell, David A Morrow, Petr Jarolim, et al.
Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2023
Detecting isolated cognitive relapses in persons with MSSarah A Morrow, Zachary L Weinstock, Omid Mirmosayyeb, et al.
European Heart Journal|March 24, 2021
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trialKazuma Oyama, Robert P Giugliano, David D Berg, et al.
Journal of Cardiac Surgery|June 3, 2020
Left ventricle unloading strategies in ECMO: A single-center experienceLaura M Piechura, Antonio Coppolino, Gita N Mody, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 20, 2005
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart StudyJames A de Lemos, Andreas Zirlik, Uwe Schönbeck, et al.
European Heart Journal|June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
FEBS Open Bio|October 8, 2020
Cystatin C regulates the cytotoxicity of infection-induced endothelial-derived β-amyloidRon Balczon, Kyle A Morrow, Silas Leavesley, et al.
Pageof 95

Showing results (681-690 of 942) with videos related to

Sort By:
Pageof 95
Journal of Pediatric Surgery|December 10, 2014
Patterns of surgical practice in very low birth weight neonates born in the United States: a Vermont Oxford Network analysisEric A Sparks, Ivan M Gutierrez, Jeremy G Fisher, et al.
The American Journal of Cardiology|August 30, 2008
Outcomes of patients with acute coronary syndrome and previous coronary artery bypass grafting (from the Pravastatin or Atorvastatin Evaluation and Infection Therapy [PROVE IT-TIMI 22] and the Aggrastat to Zocor [A to Z] trials)Emmanouil S Brilakis, James A de Lemos, Christopher P Cannon, et al.
Journal of the American College of Cardiology|April 15, 2014
Fibroblast growth factor-23, cardiovascular prognosis, and benefit of angiotensin-converting enzyme inhibition in stable ischemic heart diseaseJacob A Udell, David A Morrow, Petr Jarolim, et al.
Circulation|February 15, 2015
Vorapaxar in patients with diabetes mellitus and previous myocardial infarction: findings from the thrombin receptor antagonist in secondary prevention of atherothrombotic ischemic events-TIMI 50 trialMatthew A Cavender, Benjamin M Scirica, Marc P Bonaca, et al.
Multiple Sclerosis (Houndmills, Basingstoke, England)|September 30, 2023
Detecting isolated cognitive relapses in persons with MSSarah A Morrow, Zachary L Weinstock, Omid Mirmosayyeb, et al.
European Heart Journal|March 24, 2021
Serial assessment of biomarkers and the risk of stroke or systemic embolism and bleeding in patients with atrial fibrillation in the ENGAGE AF-TIMI 48 trialKazuma Oyama, Robert P Giugliano, David D Berg, et al.
Journal of Cardiac Surgery|June 3, 2020
Left ventricle unloading strategies in ECMO: A single-center experienceLaura M Piechura, Antonio Coppolino, Gita N Mody, et al.
Arteriosclerosis, Thrombosis, and Vascular Biology|August 20, 2005
Associations between soluble CD40 ligand, atherosclerosis risk factors, and subclinical atherosclerosis: results from the Dallas Heart StudyJames A de Lemos, Andreas Zirlik, Uwe Schönbeck, et al.
European Heart Journal|June 30, 2007
Efficacy and safety of the low-molecular weight heparin enoxaparin compared with unfractionated heparin across the acute coronary syndrome spectrum: a meta-analysisSabina A Murphy, Charles Michael Gibson, David A Morrow, et al.
FEBS Open Bio|October 8, 2020
Cystatin C regulates the cytotoxicity of infection-induced endothelial-derived β-amyloidRon Balczon, Kyle A Morrow, Silas Leavesley, et al.
Pageof 95